Target Name: NPTN-IT1
NCBI ID: G101241892
Review Report on NPTN-IT1 Target / Biomarker Content of Review Report on NPTN-IT1 Target / Biomarker
NPTN-IT1
Other Name(s): lncRNA-LET | LncRNA-LET | NPTN intronic transcript 1

NPTN-IT1: A Drug Target / Disease Biomarker

NPTN-IT1 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a key regulator of the neural plasticity, which is the ability of the brain to adapt and change over time. NPTN-IT1 has been shown to play a crucial role in the regulation of neural plasticity, and is Therefore, it is a potential drug target or biomarker for various neurological and psychiatric disorders.

One of the key functions of NPTN-IT1 is its role in the regulation of synaptic plasticity, which is the ability of the connections between neurons to change and adapt over time. NPTN-IT1 helps to regulate the formation of new synapses, as well as the strengthening or termination of existing synapses. This is important for the development and maintenance of neural circuits, and is therefore a key factor in the regulation of learning and memory.

In addition to its role in synaptic plasticity, NPTN-IT1 has also been shown to play a key role in the regulation of neurotransmitter release and action. NPTN-IT1 is a known regulator of the release of neurotransmitters such as dopamine and glutamate, which are important for the regulation of mood, emotion, and learning. NPTN-IT1 has been shown to play a crucial role in the regulation of the release of dopamine, and is therefore a potential drug target for the treatment of disorders such as depression and schizophrenia.

NPTN-IT1 is also involved in the regulation of the growth and differentiation of neural cells. NPTN-IT1 has been shown to play a key role in the regulation of the growth and differentiation of neural stem cells, which are important for the development and maintenance of neural circuits. NPTN-IT1 has also been shown to play a role in the regulation of the differentiation of neural progenitor cells, which are important for the development of functional neural circuits.

In addition to its role in neural plasticity, NPTN-IT1 has also been shown to play a key role in the regulation of inflammation and immune responses. NPTN-IT1 is a known regulator of the production of pro-inflammatory cytokines, which are important for the regulation of inflammation and immune responses. NPTN-IT1 has been shown to play a crucial role in the regulation of the production of these cytokines, and is therefore a potential drug target for the treatment of autoimmune disorders.

NPTN-IT1 is also involved in the regulation of the regulation of cell survival. NPTN-IT1 has been shown to play a key role in the regulation of cell survival, which is important for the regulation of cellular processes such as cell division, apoptosis, and autophagy. NPTN-IT1 has been shown to play a crucial role in the regulation of cell survival by regulating the production of pro- apoptotic cytokines and the inhibition of anti-apoptotic cytokines.

In conclusion, NPTN-IT1 is a protein that is involved in the regulation of various cellular processes that are important for the development and maintenance of neural circuits. NPTN-IT1 has been shown to play a crucial role in the regulation of synaptic plasticity, neurotransmitter release and action, growth and differentiation of neural cells, inflammation and immune responses, and cell survival. Therefore, NPTN-IT1 is a potential drug target or biomarker for various neurological and psychiatric disorders.

Protein Name: NPTN Intronic Transcript 1

The "NPTN-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPTN-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2